Debunking Common Barriers to Pediatric HIV Disclosure
Debunking Common Barriers to Pediatric HIV Disclosure
复制标题
DOI：
10.1093/tropej/fmq013
复制
发表时间：
2010-12-01
影响因子：
2
通讯作者：
Domek, Gretchen J.
中科院分区：
文献类型：
--
作者：
Domek, Gretchen J.
随着艾滋病毒抗体阳性儿童继续获得更多的抗逆转录病毒治疗并存活到青年期，照料者面临着向儿童披露其艾滋病毒状况的困难过程。尽管披露对心理健康、心理社会发展、照顾者福祉、治疗依从性和未来规划有许多已被证明的好处，但这一过程仍然经常遇到阻力。本文讨论了推迟或避免披露儿童艾滋病毒状况的主要原因。每一个披露的障碍进行了讨论和揭穿，作为一个不充分的理由，推迟披露过程已显示产生的积极效益。艾滋病毒披露对儿童来说是一个关键且多方面的问题。这种过程已被证明是最好的涉及多学科的支持团队，协助照顾者在不断调整披露的讨论，以满足每个孩子的发展需要和理解随着时间的推移。
As HIV-positive children continue to gain more access to antiretroviral therapy and survive into young adulthood, caregivers face the difficult process of disclosing a child's HIV status to that child. Although disclosure has many proven benefits for mental health, psychosocial development, caregiver well-being, treatment adherence and future planning, such a process is still often met with resistance. This article discusses the main reasons given for delaying or avoiding disclosure of a child's HIV status. Each barrier to disclosure is discussed and debunked as an insufficient reason to delay the positive benefits that the disclosure process has shown to produce. HIV disclosure is a critical and multifaceted issue in children. Such a process has been shown to best involve a multi-disciplinary support team that assists caregivers in continually adapting the disclosure discussion to meet the developmental needs and understanding of each individual child over time.